BFA
UPI

BlackRock Fund Advisors’s UROPLASTY INC-NEW UPI Stock Holding History

BlackRock Fund Advisors’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-72,033
Closed -$88K – 3999
2015
Q1 		$88K Buy
72,033
+6,270
+10% +$8.44K ﹤0.01% 3644
2014
Q4 		$135K Buy
65,763
+4,698
+8% +$11.2K ﹤0.01% 3567
2014
Q3 		$153K Sell
61,065
-4,437
-7% -$11.6K ﹤0.01% 3558
2014
Q2 		$176K Buy
65,502
+1,872
+3% +$5.88K ﹤0.01% 3535
2014
Q1 		$231K Buy
63,630
+7,722
+14% +$30.2K ﹤0.01% 3423
2013
Q4 		$153K Buy
55,908
+2,340
+4% +$7.13K ﹤0.01% 3505
2013
Q3 		$177K Buy
53,568
+4,212
+9% +$11.8K ﹤0.01% 3418
2013
Q2 		$102K Buy
+49,356
New +$113K ﹤0.01% 3517

BlackRock Fund Advisors's UPI Position: Q2 2015 in Review

BlackRock Fund Advisors sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 72,033 shares — an estimated $88K sold.

BlackRock Fund Advisors first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $231K in Q1 2014. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

  • BlackRock Fund Advisors reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 72,033 UROPLASTY INC-NEW shares in Q2 2015, an estimated $88K.
  • BlackRock Fund Advisors first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
  • BlackRock Fund Advisors's UROPLASTY INC-NEW position peaked at $231K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.